Björklund Pharma

  • Home
  • Company
  • Science & Innovation
  • Publications
  • Media
  • Contact
    • Contact Form

New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection

October 5, 2022 By admin

Working with researchers from Greece (Institute of Chemical Biology, NHRF) and Italy (University of Sassari), Geir Bjørklund was part of a team who identified potential inhibitors that could block the SARS-CoV-2-infection of immune cells. We found that human E3 ligases interact with viral partners through their Zn(II) binding domains. The RING (Really Interesting New Gene) mediated formation of stable SARS-CoV-2-E3 complexes indicates a critical role of RING domains in immune system disruption by SARS-CoV-2-infection. Our paper is currently being published in the Journal of Trace Elements in Medicine and Biology.

Reference

Chasapis CT, Perlepes SP, Bjørklund G, Peana M. Structural modeling of protein ensembles between E3 RING ligases and SARS-CoV-2: the role of zinc binding domains. J Trace Elem Med Biol 2022. doi: 10.1016/j.jtemb.2022.127089.

 

Filed Under: Press & News, Research News Tagged With: Zinc

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment

RSS CONEM Autism Research

  • Zinc, Copper, and Autism Spectrum Disorder
  • Digestive Enzyme Therapy: A Possible Option in Autism Spectrum Disorder
  • Vitamin D Deficiency Correlates with Severity of Autism and Shows Improvement with Supplementation
  • ADHD, Autism, and Phenylketonuria
  • Serum Zinc and Copper Levels in Autistic Children

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2023 Björklund Pharma AS